Showing results (2611-2620 of 2,892) with videos related to

Sort By:
Pageof 290
The Journal of Clinical Endocrinology and Metabolism|July 15, 2015
Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Aubrey A Carhill, Danielle R Litofsky, Douglas S Ross, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2015
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistanceT Kostyanev, M J M Bonten, S O'Brien, et al.
Critical Care Nurse|December 3, 2014
Improving patients' readiness for coronary artery bypass graft surgeryKristine Chaisson, Mary Sanford, Richard A Boss, et al.
Science Advances|January 1, 2025
Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesisXiujie Li-Harms, Jingjun Lu, Yu Fukuda, et al.
ESMO Open|November 3, 2023
Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO studyC B Westphalen, J Federer-Gsponer, C Pauli, et al.
European Urology Oncology|May 18, 2020
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 StudyAndrea Necchi, Daniele Raggi, Patrizia Giannatempo, et al.
The Oncologist|May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for TherapyAparna R Parikh, Yuting He, Ted S Hong, et al.
JAMA|August 20, 2009
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006Harlan M Krumholz, Yun Wang, Jersey Chen, et al.
NPJ Breast Cancer|April 17, 2021
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancerEdaise M da Silva, Pier Selenica, Mahsa Vahdatinia, et al.
JCO Precision Oncology|September 14, 2020
Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of ThymomaLucas R Massoth, Yin P Hung, Dora Dias-Santagata, et al.
Pageof 290